SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-21-000654
Filing Date
2021-02-16
Accepted
2021-02-16 13:29:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT arrowmark-xers123120a1.htm SC 13G/A 52653
  Complete submission text file 0001172661-21-000654.txt   54272
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90534 | Film No.: 21635601
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
ArrowMark Colorado Holdings LLC (Filed by) CIK: 0001483859 (see all company filings)

IRS No.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A